Eric (Ye) Zou of Merits & Tree Law Offices gives an overview of the core elements and key significance of a new pilot scheme which maps out a new way for foreign investors to access China’s flourishing financial markets
In the first part of a series of articles, Jianwei (Jerry) Fang, Ke Dong, and Haoyi Sun of Zhong Lun Law Firm outline the general jurisdiction rules governing foreign-related civil litigation in China under the 2024 Civil Procedure Law, and explain the statutory framework, key jurisdictional bases, and procedural considerations that foreign companies and in-house counsel need to understand when facing potential lawsuits in Chinese courts
Wei Huang, managing partner, and Kexin Chen, associate, at Beijing Tian Yuan Law Firm provide a comprehensive interpretation of a core provision of China’s revised Anti-Unfair Competition Law and its impact on enterprises of all sizes
A leading international healthcare General Counsel in the region provides an exclusive in-house perspective on the current law and practice of cross-border data transfer in China
Casper Sek of Jingtian & Gongcheng examines new guidance from TC260 which looks likely to become an essential component in companies’ personal information protection toolkits
The intersection between intellectual property and artificial intelligence raises challenging and significant legal issues. Danlei Wu of Fangda Partners examines China’s first case relating to the structure and parameters of an AI model
CEO and General Counsel of MyoMed Bio, explains how legal strategy—spanning IP, regulatory compliance, and cross-border structuring—is essential for enabling clinical development, managing geopolitical and data protection risks, and aligning biotech operations across China, the U.S., and Australia.
Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model
Globally, the accelerating spread of AI shows no sign of abating, and laws and regulations are under greater pressure to keep up. Wenpei Yu and Yunsi Hu of Lifeng Partners, together with Dr. Anja Geller of Redeker Sellner Dahs, provide an overview of the similarities and differences between the approaches taken in the EU and China, and what the future may hold
